NMS·Healthcare·$1.5B·#111 / 520 in Healthcare
IMCR Immunocore Holdings plc
63SOLID
CATEGORY BREAKDOWN
GROWTH46
QUALITY79
STABILITY69
VALUATION84
GOVERNANCE31
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+29.0%
46
> 50% strong
Gross Margin
Revenue retained after direct costs
98.7%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
524 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
114.6%
7
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.6x
84
< 3x strong
Rule of 40
Growth rate plus operating margin
18
46
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.1%
1
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.3%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE IMCR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when IMCR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.